A new report published in the July 26 issue of Archives of Internal Medicine claims many men who are diagnosed with prostate cancer undergo aggressive therapy, even when they have low PSA scores and low-risk disease, saying "these results underscore the fact that PSA level, the current biomarker, is not a sufficient basis for treatment decisions."
"When it comes to 'overtreatment,' the PSA test is not to blame it's what happens next," said Skip Lockwood, ZERO's CEO.
Read more at Medical News Today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment